SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-068576
Filing Date
2015-08-31
Accepted
2015-08-31 14:31:53
Documents
1
Period of Report
2015-08-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 22788
  Complete submission text file 0001209191-15-068576.txt   24924
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 2813641555
Essex Woodlands Health Ventures VIII, L.P. (Reporting) CIK: 0001632026 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 151084539

Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 2813641555
Essex Woodlands Health Ventures VIII, L.L.C. (Reporting) CIK: 0001632027 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 151084540